+
Site Tour
EPIC™ MITRAL AND AORTIC TISSUE VALVES
SURGICAL VALVE SOLUTIONS

 

Excellent hemodynamic performance, lasting durability, and a design that preserves future valve-in-valve treatment options.*

The platform for possibility

The Epic™ platform has been proven over time and defined by strong hemodynamics, intuitive implantability, a future-forward design and more. The platform boasts the low ventricular protrusion in all valve sizes, a flexible polymer stent, individually selected porcine leaflets to ensure optimal coaptation and a flexible sewing cuff designed to minimize both suture drag and paravalvular leak. Now we offer even more for lifetime management with the Epic™ Elite the addition of an expansion zone - for low pressure, predictable expansion in a future intervention.

  • PORCINE LEAFLETS
  • EXPANSION ZONE
  • ADAPTIVE CUFF
  • UNIQUE PERICARDIAL SHIELD
  • LOW AORTIC PROTRUSION
  • PORCINE LEAFLETS
    Natural leaflet tissue with maximal opening (no muscle bar), complete leaflet coaptation (no central gap), no leaflet curtaining, and less calcification with reduced risk for stroke during reintervention2

  • EXPANSION ZONE
    expands at specific location at low pressures to accommodate a larger transcatheter valve in a future valve-in-valve procedure1*

  • ADAPTIVE CUFF
    Engineered to:

    • Allow maximum flexibility and easy passage through all anatomies
    • Prevent paravalvular leaks by sealing in all planes and minimize parachuting resistance when delivering the valve onto the annulus
  • UNIQUE PERICARDIAL SHIELD
    Provides a tissue-to-tissue interface to help prevent the risk of abrasion

  • LOW AORTIC PROTRUSION
    Mitigates the risk of coronary obstruction and sinus jailing

    Flexfit™ polymer stent

    • Eases implant
    • Accommodates minimally invasive surgery
    • Reduces leaflet stress by absorbing shock of each heartbeat
Epic Max
1
2
3
4
5
  1. PORCINE LEAFLETS


    Natural leaflet tissue with maximal opening (no muscle bar), complete leaflet coaptation (no central gap), no leaflet curtaining, and less calcification with reduced risk for stroke during reintervention2

  2. EXPANSION ZONE


    expands at specific location at low pressures to accommodate a larger transcatheter valve in a future valve-in-valve procedure1*

  3. ADAPTIVE CUFF

    Engineered to:

    • Allow maximum flexibility and easy passage through all anatomies
    • Prevent paravalvular leaks by sealing in all planes and minimize parachuting resistance when delivering the valve onto the annulus
  4. UNIQUE PERICARDIAL SHIELD

    Provides a tissue-to-tissue interface to help prevent the risk of abrasion

  5. LOW AORTIC PROTRUSION

    Mitigates the risk of coronary obstruction and sinus jailing

    Flexfit™ polymer stent

    • Eases implant
    • Accommodates minimally invasive surgery
    • Reduces leaflet stress by absorbing shock of each heartbeat

*Expansion zone available on sizes 19 mm - 27 mm

Radiopaque markers at annulus and stent posts

enhance visibility for future valve-in-valve procedures; gap in annulus marker denotes location of future expansion

Connext
Live

REGISTER FOR OUR
VIRTUAL VENUE

Hear expert opinions first hand and collaborate on best practices.

Find out more

TV

References

*The safety and effectiveness of valve-in-valve procedures in Epic Valves has not been established.

  1. Epic™ Elite Instructions for Use
  2. Keshishi M, et al. "Comparison of Modes of Failure and Clinical Outcomes Between Explanted Porcine and Bovine Pericardial Bioprosthetic Valves." Cardiovascular Pathology (2023): 107516.

© Abbott 2026. All rights reserved. MAT-2682529 v1.0

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline